Back to Atlas
BSemi-durableStandard research/education caution
CMP-0188
Approved/used in limited markets historically
Dihydrotestosterone / Androstanolone
Endocrine / Androgen
Strong androgenic signaling with limited muscle-selective anabolic index
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Endogenous androgen / AAS
- Primary mechanism
- Potent AR agonist; A:A ratio low vs androgenic activity
- Primary market use
- Androgen replacement niche
Pharmacology
- Molecular weight (Da)
- 290.44
- Oral bioavailability
- Oral poor; topical/transdermal or buccal routes historically
- Half-life
- ~2-3 h
- Route tags
- Route-dependent / verify
- Evidence level
- Human/clinical
- Clinical status
- Approved/used in limited markets historically
- Value-for-money score
- 4 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
DHT is potent androgenically and non-aromatizable; not usually valued as a mass-building anabolic.